向精神薬の世界市場レポート 2025年

向精神薬の市場規模は、今後数年で急成長が見込まれます。2029年には年間平均成長率（CAGR）17.5％で114億6,000万米ドルに成長します。予測期間の成長は、ストレスや認知的要求の増加、グローバル化、可処分所得の増加、メンタルヘルス意識の高まり、新興市場の拡大などに起因すると考えられます。予測期間の主な動向としては、天然素材や植物由来の向精神薬、デジタル向精神薬、経頭蓋刺激装置、持続可能で倫理的な調達、異業種コラボレーションなどが挙げられます。

健康とウェルネスへの投資の高まりが、今後の向精神薬市場の成長を牽引すると予想されます。健康とウェルネスは一般的に、個人が精神的な健康と肉体的な幸福を達成するために取るアプローチとして理解されています。これは、健康とウェルネス産業の徹底検証を網羅しています。向精神薬は、個人の健康とウェルネスをサポートする重要な役割を果たします。したがって、ヘルスケアとウェルネスの需要が高まるにつれ、向精神薬のニーズも高まるでしょう。例えば、2024年5月、英国の政府機関Office for National Statisticsは、2022年から2023年にかけてのヘルスケア支出は名目ベースで5.6%増加したと報告しています。したがって、ヘルスケアとウェルネスへの支出の増加が向精神薬市場を牽引しています。

生活習慣病の罹患率の上昇が、今後の向精神薬市場の成長を牽引すると予想されます。生活習慣病は、一般的に非感染性疾患（NCDs）または慢性疾患と呼ばれ、主に感染性要因ではなく、不健康な生活習慣の選択や行動に起因する健康問題の集合体です。肥満や糖尿病などの生活習慣病を患う人は、認知機能の低下、ストレス、エネルギーレベルの低下に直面することが多くあります。向精神薬は、認知能力を高め、ストレスを管理し、エネルギーを増加させ、体重管理を助けるために利用されます。例えば、スイスに本部を置く国連の専門機関である世界保健機関（WHO）は2022年9月、全世界で年間4,100万人が死亡し、その74％が非感染性疾患（NCDs）または慢性疾患に起因していると報告しました。その内訳は、心血管疾患による死亡が1,790万人、がんによる死亡が930万人、慢性呼吸器疾患による死亡が410万人、糖尿病による死亡が200万人となっています。このように、生活習慣病の有病率の上昇が向精神薬市場の成長を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の向精神薬市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の向精神薬市場：成長率分析
• 世界の向精神薬市場の実績：規模と成長、2019～2024年
• 世界の向精神薬市場の予測：規模と成長、2024～2029年、2034年
• 世界の向精神薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の向精神薬市場：薬の種類別、実績と予測、2019～2024年、2024～2029年、2034年
• 処方箋向精神薬
• 市販向精神薬
• 世界の向精神薬市場：形態別、実績と予測、2019～2024年、2024～2029年、2034年
• カプセルまたは錠剤
• 粉末
• ドリンク
• その他
• 世界の向精神薬市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• オンライン
• オフライン
• 世界の向精神薬市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 記憶力強化
• 気分と抑うつ
• 注意力と集中力
• 長寿とアンチエイジング
• 睡眠と回復
• 不安
• 世界の向精神薬市場：処方箋向精神薬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 覚醒剤
• 認知機能向上剤
• その他の処方箋向精神薬
• 世界の向精神薬市場：市販向精神薬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 天然向精神薬
• 合成向精神薬
• 向精神薬ブレンド

第7章 地域別・国別分析

• 世界の向精神薬市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の向精神薬市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 向精神薬市場：競合情勢
• 向精神薬市場：企業プロファイル
  • Accelerated Intelligence Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AlternaScript Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Health Via Modern Nutrition Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Mental Mojo LLC. Overview, Products and Services, Strategy and Financial Analysis
  • Peak Nootropics Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• PureLife Bioscience Co. Ltd.
• TruBrain
• PepsiCo
• Superior Supplement Manufacturing
• Equinox Nutraceuticals
• Natural Stacks Inc.
• Gaia Herbs Farms.
• Kimera Koffee LLC.
• Onnit Labs LLC .
• Reckitt Benckiser Group plc.
• OUTLIERS INC.
• Teva Pharmaceutical Industries Ltd.
• United Pharmacies o
• Clarity Nootropics
• OptiMind

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 向精神薬市場2029：新たな機会を提供する国
• 向精神薬市場2029：新たな機会を提供するセグメント
• 向精神薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Nootropics, also known as smart drugs or cognitive enhancers, refer to substances that aim to enhance memory and cognitive function with a stimulant effect. These substances are utilized to boost brain performance and include caffeine, creatine, vitamins, and minerals. Nootropics are often used to increase memory, improve strength, or enhance other cognitive functions. It's important to note that while they may affect memory, thinking, or other mental functions, they do not treat diseases.

The main types of drugs categorized as nootropics include prescription nootropics and over-the-counter (OTC) nootropics. Prescription nootropics are often utilized to provide stimulant effects and may be prescribed to counteract symptoms associated with medical conditions such as attention deficit hyperactivity disorder (ADHD), Alzheimer's disease, or narcolepsy. Nootropics are available in various forms, including capsules or tablets, powder, drinks, and others, and are distributed through multiple channels, both online and offline. They find application in memory enhancement, mood and depression treatment, attention and focus improvement, longevity and anti-aging efforts, sleep and recovery promotion, and anxiety treatment.

The nootropics market research report is one of a series of new reports from The Business Research Company that provides nootropics market statistics, including nootropics industry global market size, regional shares, competitors with a nootropics market share, detailed nootropics market segments, market trends and opportunities, and any further data you may need to thrive in the nootropics industry. This nootropics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nootropics market size has grown rapidly in recent years. It will grow from $5.23 billion in 2024 to $6.01 billion in 2025 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to aging population, regulatory support, increased research and development, e-commerce expansion, rise in esports.

The nootropics market size is expected to see rapid growth in the next few years. It will grow to $11.46 billion in 2029 at a compound annual growth rate (CAGR) of 17.5%. The growth in the forecast period can be attributed to increasing stress and cognitive demands, globalization, rising disposable incomes, rising mental health awareness, expansion of emerging markets. Major trends in the forecast period include natural and plant-based nootropics, digital nootropics, transcranial stimulation devices, sustainable and ethical sourcing, inndustry collaboration.

The rising investment in health and wellness is anticipated to drive the growth of the nootropics market in the future. Health and wellness are typically understood as approaches individuals take to achieve mental health and physical well-being. This encompasses a thorough exploration of the health and wellness industry. Nootropics play a significant role in supporting an individual's health and wellness; therefore, as the demand for healthcare and wellness rises, the need for nootropics will also increase. For example, in May 2024, the Office for National Statistics, a UK-based government department, reported that healthcare spending rose by 5.6% in nominal terms from 2022 to 2023, a significant increase compared to the 0.9% growth noted in 2022. Hence, the growing expenditure on healthcare and wellness is driving the nootropics market.

The rising incidence of lifestyle diseases is expected to drive the growth of the nootropics market in the future. Lifestyle diseases, commonly referred to as non-communicable diseases (NCDs) or chronic diseases, are a collection of health issues primarily resulting from unhealthy lifestyle choices and behaviors rather than infectious agents. Individuals suffering from lifestyle diseases such as obesity and diabetes often face cognitive decline, stress, and decreased energy levels. Nootropics are utilized to enhance cognitive abilities, manage stress, increase energy, and aid in weight management. For example, in September 2022, the World Health Organization, a Switzerland-based specialized agency of the United Nations, reported that there were 41 million deaths annually worldwide, with 74% attributed to non-communicable diseases (NCDs) or chronic diseases. This included 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the rising prevalence of lifestyle diseases is propelling the growth of the nootropics market.

The popularity of vegan nootropics is increasing in the global nootropics market. Leading companies in the nootropics sector are pursuing new organic product innovations to satisfy consumer demand and maintain their market position. For example, in July 2022, BioAdaptives Inc., a US-based producer of natural supplements derived from plants and algae, introduced MindMemory, an advanced nootropic designed to enhance memory, mental focus, and concentration. This new product offers a gradual and smooth effect, unlike coffee, which can cause a sudden surge of adrenaline.

Leading companies in the nootropics market are creating multi-flavored nootropics to appeal to a diverse audience with different tastes and preferences. Multi-flavored nootropics are cognitive-enhancing supplements offered in various flavors to enhance taste appeal. For example, in June 2023, Rollagranola, a UK-based food and beverage company, launched a range of nootropics featuring four unique flavors aimed at addressing both nutritional requirements and taste preferences. This innovative lineup includes Calm, Energize, Body and Soul, and Complete Vegan. Calm is designed to promote relaxation and stress reduction with ingredients like ashwagandha and matcha green tea. Energize features a cappuccino and white chocolate blend to boost focus and energy, incorporating lion's mane, caffeine, and panax ginseng. Body and Soul combines summer berries and walnuts to support physical and mental well-being, using ingredients like creatine, maca, ginkgo, and panax ginseng. Finally, Complete Vegan is a granola specifically designed for vegans, offering essential nutrients, pea protein, and key vitamins to address deficiencies and enhance focus, memory, and mood.

In August 2024, Paradigm Sports, a US-based sports management services provider, formed a partnership with Ten Percent Club. This collaboration aims to educate athletes about the advantages of nootropics for enhancing cognitive performance while broadening product offerings in the sports industry to optimize mental preparation and recovery. The partnership seeks to redefine athlete performance through innovative cognitive support solutions. Ten Percent Club is a UK-based company that sells nootropic-based supplements, including Nootropics.

Major companies operating in the nootropics market include Accelerated Intelligence Inc., AlternaScript Inc. Health Via Modern Nutrition Inc., Mental Mojo LLC., Peak Nootropics, PureLife Bioscience Co. Ltd., TruBrain, PepsiCo, Superior Supplement Manufacturing, Equinox Nutraceuticals, Natural Stacks Inc., Gaia Herbs Farms., Kimera Koffee LLC., Onnit Labs LLC., Reckitt Benckiser Group plc., OUTLIERS INC., Teva Pharmaceutical Industries Ltd., United Pharmacies o, Clarity Nootropics, OptiMind, HVMN Inc., BioAdaptives Inc., Powder City

North America was the largest region in the nootropics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nootropics market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the nootropics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The nootropics market includes revenues earned by entities by modafinil (provigil), adderall, methylphenidate (ritalin), memantine (axura), caffeine, l-theanine, and omega-3 fatty acids. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nootropics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nootropics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nootropics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nootropics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: Prescription Nootropics; OTC Nootropics
• 2) By Form: Capsules or Tablets; Powder; Drinks; Other Forms
• 3) By Distribution Channel: Offline; Online
• 4) By Application: Memory Enhancement; Mood and Depression; Attention and Focus; Longevity and Anti-aging; Sleep and Recovery; Anxiety
• Subsegments:
• 1) By Prescription Nootropics: Stimulants; Cognitive Enhancers; Other Prescription Nootropics
• 2) By Over-the-Counter (OTC) Nootropics: Natural Nootropics; Synthetic Nootropics; Nootropic Blends
• Companies Mentioned: Accelerated Intelligence Inc.; AlternaScript Inc. Health Via Modern Nutrition Inc.; Mental Mojo LLC.; Peak Nootropics; PureLife Bioscience Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Nootropics Market Characteristics

3. Nootropics Market Trends And Strategies

4. Nootropics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Nootropics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Nootropics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Nootropics Market Growth Rate Analysis
• 5.4. Global Nootropics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Nootropics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Nootropics Total Addressable Market (TAM)

6. Nootropics Market Segmentation

• 6.1. Global Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prescription Nootropics
• OTC Nootropics
• 6.2. Global Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Capsules or Tablets
• Powder
• Drinks
• Other Forms
• 6.3. Global Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Online
• Offline
• 6.4. Global Nootropics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Memory Enhancement
• Mood and Depression
• Attention and Focus
• Longevity and Anti-aging
• Sleep and Recovery
• Anxiety
• 6.5. Global Nootropics Market, Sub-Segmentation Of Prescription Nootropics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stimulants
• Cognitive Enhancers
• Other Prescription Nootropics
• 6.6. Global Nootropics Market, Sub-Segmentation Of Over-the-Counter (OTC) Nootropics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Nootropics
• Synthetic Nootropics
• Nootropic Blends

7. Nootropics Market Regional And Country Analysis

• 7.1. Global Nootropics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Nootropics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Nootropics Market

• 8.1. Asia-Pacific Nootropics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Nootropics Market

• 9.1. China Nootropics Market Overview
• 9.2. China Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Nootropics Market

• 10.1. India Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Nootropics Market

• 11.1. Japan Nootropics Market Overview
• 11.2. Japan Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Nootropics Market

• 12.1. Australia Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Nootropics Market

• 13.1. Indonesia Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Nootropics Market

• 14.1. South Korea Nootropics Market Overview
• 14.2. South Korea Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Nootropics Market

• 15.1. Western Europe Nootropics Market Overview
• 15.2. Western Europe Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Nootropics Market

• 16.1. UK Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Nootropics Market

• 17.1. Germany Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Nootropics Market

• 18.1. France Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Nootropics Market

• 19.1. Italy Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Nootropics Market

• 20.1. Spain Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Nootropics Market

• 21.1. Eastern Europe Nootropics Market Overview
• 21.2. Eastern Europe Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Nootropics Market

• 22.1. Russia Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Nootropics Market

• 23.1. North America Nootropics Market Overview
• 23.2. North America Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Nootropics Market

• 24.1. USA Nootropics Market Overview
• 24.2. USA Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Nootropics Market

• 25.1. Canada Nootropics Market Overview
• 25.2. Canada Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Nootropics Market

• 26.1. South America Nootropics Market Overview
• 26.2. South America Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Nootropics Market

• 27.1. Brazil Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Nootropics Market

• 28.1. Middle East Nootropics Market Overview
• 28.2. Middle East Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Nootropics Market

• 29.1. Africa Nootropics Market Overview
• 29.2. Africa Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Nootropics Market Competitive Landscape And Company Profiles

• 30.1. Nootropics Market Competitive Landscape
• 30.2. Nootropics Market Company Profiles
  • 30.2.1. Accelerated Intelligence Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AlternaScript Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Health Via Modern Nutrition Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Mental Mojo LLC. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Peak Nootropics Overview, Products and Services, Strategy and Financial Analysis

31. Nootropics Market Other Major And Innovative Companies

• 31.1. PureLife Bioscience Co. Ltd.
• 31.2. TruBrain
• 31.3. PepsiCo
• 31.4. Superior Supplement Manufacturing
• 31.5. Equinox Nutraceuticals
• 31.6. Natural Stacks Inc.
• 31.7. Gaia Herbs Farms.
• 31.8. Kimera Koffee LLC.
• 31.9. Onnit Labs LLC .
• 31.10. Reckitt Benckiser Group plc.
• 31.11. OUTLIERS INC.
• 31.12. Teva Pharmaceutical Industries Ltd.
• 31.13. United Pharmacies o
• 31.14. Clarity Nootropics
• 31.15. OptiMind

32. Global Nootropics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nootropics Market

34. Recent Developments In The Nootropics Market

35. Nootropics Market High Potential Countries, Segments and Strategies

• 35.1 Nootropics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Nootropics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Nootropics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer